DeepSnitch AI’s DSNT presale “surges 135%” as January launch chatter spikes
20 January 2026
1 min read

DeepSnitch AI’s DSNT presale “surges 135%” as January launch chatter spikes

London, 20 January 2026, 14:44 (GMT)

  • Crypto promo posts claimed DeepSnitch AI’s DSNT presale price jumped roughly 130% to 135%, with the project pulling in around $1.2 million in funding.
  • One post noted that investors were shifting away from rival presales Remittix and Pepeto, pointing to an uncertain launch date for Remittix.
  • Bitcoin dropped roughly 2%, while ether tumbled around 3%, as broader markets grew cautious, weighing on smaller tokens.

DeepSnitch AI, a crypto venture promoting AI-powered tools for spotting token risks and issuing trading alerts, is gaining traction on crypto news platforms ahead of its January launch. Posts tout the DSNT token’s presale price soaring over 130%.

The marketing push arrives amid a selloff in major cryptocurrencies as investors turn cautious. Bitcoin dropped 2% to $91,090, while ether slid 3.3% to $3,104, according to Reuters, with traders factoring in geopolitical tensions and a weakening dollar. 1

Presales—early token sales before wider exchange listings—are key because they attract quick retail capital even amid low liquidity. Prices here are generally dictated by the issuer, not the open market, which often leads to sharp jumps once trading kicks off.

CoinCentral reported that DeepSnitch’s presale had reached “stage 4 of 15” at $0.03538, climbing over 130% from the starting price of $0.01510. The project is now under two weeks away from launching its full platform. 2

The post pitched the idea of “AI agents” using a checklist method to vet tokens before purchase. This includes tools that analyze smart contracts — self-executing code governing blockchain transactions — for structural flaws and signs of suspicious behavior.

A separate BlockchainReporter post noted investor focus drifting from other presales, highlighting Remittix and a meme token called Pepeto. The piece said Remittix’s launch date remains uncertain. Pepeto, meanwhile, aims for a first-quarter 2026 debut after pulling in over $7.1 million, including funds raised through what it described as a live demo exchange.

Bitget’s news site featured a BlockchainReporter article promoting DeepSnitch AI as a frontrunner among “AI coins,” but included a clear disclaimer stating the piece expressed the author’s opinion and should not be taken as investment advice. 3

On the broader market front, on-chain data is beginning to reveal strains. For the first time since late 2023, “Bitcoin holders realizing losses” over a 30-day span have been recorded, CryptoQuant’s head of research Julio Moreno noted on X, as reported by Cointelegraph. 4

Claims about DSNT’s price jumps, fundraising amounts, and launch dates stem from promotional posts rather than official filings, and haven’t been independently confirmed. Presale tokens also risk delays, security problems, or sharp price volatility once they enter public trading.

DeepSnitch and its competitors now face a simple, unforgiving challenge: will their products hook users beyond the initial presale? And can the project teams support their marketing with independent audits, transparent token distributions, and listings that can be verified?

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Intel stock slides premarket despite HSBC upgrade as tariff jitters hit tech
Previous Story

Intel stock slides premarket despite HSBC upgrade as tariff jitters hit tech

Apple stock slips early as tariff jitters weigh on tech; analysts point to iPhone demand
Next Story

Apple stock slips early as tariff jitters weigh on tech; analysts point to iPhone demand

Go toTop